DANA MOORE: Open Payments
NPI 1760730139 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 38 payments from 15 companies in 2025. Trend: 2023 $587 · 2024 $798 · 2025 $894
Food & beverage: $776Education: $118
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $195 |
| Astellas Pharma US Inc | 1 | $99 |
| Lundbeck LLC | 4 | $94 |
| Novo Nordisk Inc | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| ABBVIE INC. | 2 | $61 |
| Insulet Corporation | 2 | $55 |
| Viatris Specialty LLC | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
Products named: FARXIGA, REXULTI, Ozempic, JARDIANCE, BREZTRI, Omnipod, YUPELRI, QULIPTA.
Industry payments across MO — which companies pay providers there.
